MNPHARM

MNPHARM produces vaccines and cancer treatments using transgenic plants to quickly manufacture large quantities of proteins that are safer and at a lower cost.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location White Bear Lake, MN, USA
  • Currency USD
  • Founded January 2015
  • Employees 4
  • Incorporation Type C-corp
  • Website mnpharm.com

Company Summary

MNPHARM is a contract manufacturer of recombinant proteins including antibodies and vaccines using a unique and proprietary process that combines technology advances in controlled indoor agriculture, biochemistry and personalized medical treatments.

Using transgenic plants, MNPHARM produces recombinant proteins in 6 days that could take up to 6 months using traditional methods. Our methods are safer, faster and have a lower production cost.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free